Physician profile
Brian Granger
NPI 1487658274
$473.47
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $84.94 · 2021: $34.42 · 2022: $19.11 · 2023: $20.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $111.20 | 2019 | |
| Pfizer INC. | $56.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $56.80 | 2019-2020 | |
| Abbvie INC. | $53.53 | 2021-2022 | |
| Bausch Health US, LLC | $30.86 | 2019 | |
| Novo Nordisk INC | $22.91 | 2019-2020 | |
| Allergan, INC. | $21.45 | 2020 | |
| Hikma Pharmaceuticals USA | $20.51 | 2019 | |
| Irhythm Technologies, INC. | $20.01 | 2023 | Zio Xt Patch |
| Sanofi-Aventis U.S. LLC | $17.34 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.13 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $13.78 | 2020 | |
| Currax Pharmaceuticals LLC | $12.15 | 2020 | |
| Neos Therapeutics, LP | $11.06 | 2019 | |
| Ironshore Pharmaceuticals INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Granger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.